MOORE'S COMPOUNDING PHARMACY
MOORE'S COMPOUNDING PHARMACY appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0488-2017, Class II) was initiated on September 12, 2016.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0488-2017 | Class II | Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pha | September 12, 2016 |